跳至主要内容
临床试验/NCT01302119
NCT01302119已完成3 期

A Randomized, Double-Blind, Vehicle-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of AN2690 Topical Solution, 5%, vs. Solution Vehicle in the Treatment of Onychomycosis of the Toenail in Adults

Pfizer1 个研究点 分布在 1 个国家目标入组 604 人开始时间: 2011年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
Pfizer
入组人数
604
试验地点
1
主要终点
Complete Cure (Completely Clear Nail and Negative Mycology) of Target Great Toenail at Week 52

研究概览

简要总结

The purpose of this study is to determine whether AN2690 topical solution is a safe and effective treatment for onychomycosis of the toenail.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of distal subungual onychomycosis affecting at least one great toenail
  • KOH positive at screening
  • Willingness not to use any other products including nail polish applied to the toenails during the study
  • Women of childbearing potential who are currently sexually active must agree to use contraception for the entire study period

排除标准

  • Concurrent or recent use of certain topical or systemic medications without a sufficient washout period
  • History of any significant chronic fungal disease other than onychomycosis
  • Significant confounding conditions as assessed by study doctor
  • Participated in any other trial of an investigational drug or device within 30 days or participation in a research study concurrent with this study
  • Pregnancy or lactation

研究组 & 干预措施

AN2690 Topical Solution, 5%

Experimental

AN2690 Topical Solution, 5%

干预措施: AN2690 Topical Solution, 5% (Drug)

Solution Vehicle

Placebo Comparator

Solution Vehicle

干预措施: Solution Vehicle (Drug)

结局指标

主要结局

Complete Cure (Completely Clear Nail and Negative Mycology) of Target Great Toenail at Week 52

时间窗: Week 52

No clinical evidence of onychomycosis as evidenced by normal toenail plate, no onycholysis, and no subungual hyperkeratosis, and negative KOH wet mount and negative fungal culture.

次要结局

  • Completely Clear or Almost Clear Target Great Toenail at Week 52(Week 52)
  • Treatment Success (Completely Clear or Almost Clear Nail and Negative Mycology) of Target Great Toenail at Week 52(Week 52)
  • Negative Mycology of Target Great Toenail at Week 52(Week 52)

研究者

发起方
Pfizer
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验